Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components

Virology

Volumn 352, Issue 2, 2006, Pages 418-426

  Mozdzanowska, Krystyna ^a   Feng, JingQi ^a   Eid, Mark ^a   Zharikova, Darya ^a   Gerhard, Walter ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Ab mediated protection; C1q; Complement; Influenza A virus; Virus neutralization

Indexed keywords

COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; HEAT TOLERANCE; HEAVY CHAIN; HOST CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; INFLUENZA VIRUS; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SERUM; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CELL LINE; COMPLEMENT C1Q; COMPLEMENT C3; DOGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MICE, SCID; MODELS, IMMUNOLOGICAL; MODELS, MOLECULAR; NEUTRALIZATION TESTS;

ORTHOMYXOVIRIDAE;

EID: 33747036652     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.05.008     Document Type: Article

References (36)

1. Beebe D.P., Schreiber R.D., and Cooper N.R. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement. J. Immunol. 130 (1983) 1317-1322
2. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., and Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19 (1998) 56-59
3. Britt W.J., Vugler L., and Stephens E.B. Induction of complement-dependent and-independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB). J. Virol. 62 (1988) 3309-3318
4. Caton A.J., Brownlee G.G., Yewdell J.W., and Gerhard W. The antigenic structure of the influenza virus A/PR/8/32 hemagglutinin (H1 subtype). Cell 31 (1982) 417-427
5. Chan O.T., Hannum L.G., Haberman A.M., Madaio M.P., and Shlomchik M.J. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189 (1999) 1639-1648
6. Chen J., Trounstine M., Alt F.W., Young F., Kurahara C., Loring J.F., and Huszar D. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int. Immunol. 5 (1993) 647-656
7. Chu V.C., and Whittaker G.R. Influenza virus entry and infection require host cell N-linked glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 18153-18158
8. Daniels C.A., Borsos T., Rapp H.J., Snyderman R., and Notkins A.L. Neutralization of sensitized virus by the fourth component of complement. Science 165 (1969) 508-509
9. Dimmock N.J. Neutralization of animal viruses. Curr. Top. Microbiol. Immunol. 183 (1993) 1-149
10. Edwards M.J., and Dimmock N.J. A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity. J. Gen. Virol. 82 (2001) 1387-1395
11. Feng J.Q., Mozdzanowska K., and Gerhard W. Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype. J. Virol. 76 (2002) 1369-1378
12. Furebring C., Speckner A., Mach M., Sandlie I., Norderhaug L., Borrebaeck C.A., Turesson H., and Ohlin M. Antibody-mediated neutralization of cytomegalovirus: modulation of efficacy induced through the IgG constant region. Mol. Immunol. 38 (2002) 833-840
13. Gerhard W. The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol. 260 (2001) 171-190
14. Giclas P.C., King T.E., Baker S.L., Russo J., and Henson P.M. Complement activity in normal rabbit bronchoalveolar fluid. Description of an inhibitor of C3 activation. Am. Rev. Respir. Dis. 135 (1987) 403-411
15. Hirsch R.L. The complement system: its importance in the host response to viral infection. Microbiol. Rev. 46 (1982) 71-85
16. Imai M., Sugimoto K., Okazaki K., and Kida H. Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin. Virus Res. 53 (1998) 129-139
17. Kavaler J., Caton A.J., Staudt L.M., Schwartz D., and Gerhard W. A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin. J. Immunol. 145 (1990) 2312-2321
18. Kavaler J., Caton A.J., Staudt L.M., and Gerhard W. A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response. Eur. J. Immunol. 21 (1991) 2687-2695
19. Kerr J.S., Riley D.J., and Leung K. C1q content of serum and lung lavage fluid of rats exposed to toxic levels of oxygen. Immunol. Invest. 15 (1986) 473-480
20. Knossow M., Gaudier M., Douglas A., Barrere B., Bizebard T., Barbey C., Gigant B., and Skehel J.J. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302 (2002) 294-298
21. Lakadamyali M., Rust M.J., Babcock H.P., and Zhuang X. Visualizing infection of individual influenza viruses. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 9280-9285
22. Liang S., Mozdzanowska K., Palladino G., and Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 152 (1994) 1653-1661
23. Linscott W.D., and Levinson W.E. Complement components required for virus neutralization by early immunoglobulin antibody. Proc. Natl. Acad. Sci. U.S.A. 64 (1969) 520-527
24. Mozdzanowska K., Furchner M., Washko G., Mozdzanowski J., and Gerhard W. A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J. Virol. 71 (1997) 4347-4355
25. Mozdzanowska K., Maiese K., Furchner M., and Gerhard W. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection. Virology 254 (1999) 138-146
26. Mozdzanowska K., Feng J., and Gerhard W. Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice. J. Virol. 77 (2003) 8322-8328
27. Parren P.W., and Burton D.R. The antiviral activity of antibodies in vitro and in vivo. Adv. Immunol. 77 (2001) 195-262
28. Reed L.J., and Munch H. A simple method of estimating fifty percent enpoints. Am. J. Hyg. 27 (1938) 493-497
29. Scherle P.A., Palladino G., and Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 148 (1992) 212-217
30. Sieczkarski S.B., and Whittaker G.R. Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4 (2003) 333-343
31. Skehel J.J., and Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69 (2000) 531-569
32. Vasantha S., Coelingh K.L., Murphy B.R., Dourmashkin R.R., Hammer C.H., Frank M.M., and Fries L.F. Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization. Virology 167 (1988) 433-441
33. Watford W.T., Wright J.R., Hester C.G., Jiang H., and Frank M.M. Surfactant protein A regulates complement activation. J. Immunol. 167 (2001) 6593-6600
34. Wessels M.R., Butko P., Ma M., Warren H.B., Lage A.L., and Carroll M.C. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11490-11494
35. Wiley D.C., Wilson I.A., and Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289 (1981) 373-378
36. Wilson I.A., Skehel J.J., and Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289 (1981) 366-373